Work

Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment

Year: 2019

Type: article

Abstract: Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults. Over the last two decades many new multimodal therapeutic have been developed but the poor prognosis h...

Source: Expert Opinion on Therapeutic Targets

DOI: 10.1080/14728222.2019.1628220

Authors: Rajan Patel, Jeffrey I. Traylor, Khatri Latha, Amy B. Heimberger, Shulin Li, Ganesh Rao

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G1188390601, MODELING MALIGNANT PROGRESSION IN GLIOMA, Fgl-2 targeted therapy for reversing multi-modality immune suppression, Cancer Center Support Grant

OpenAlex ID: W2953571840

FWCI: 0.543

Cites: 15

Cited by: 4

Related to: 10